Active PAR

P3360

Standard for the Performance of On-Site Oral Fluid Drug Screening Devices

This document specifies the minimally-acceptable performance requirements and associated test procedures for on-site oral fluid drug screening devices used by law enforcement agencies. The scope of this document is limited to on-site oral fluid drug screening devices used by law enforcement agencies to detect the presence of substances, such as amphetamines, benzodiazepines, cannabis, cocaine, methamphetamine, and opiates, in a driver's system that may result in impaired driving. This document does not apply to evidential breath testing used to conduct alcohol confirmation tests.

Standard Committee
IM/TET - TC41 - Traffic Enforcement Technologies
Status
Active PAR
PAR Approval
2023-03-30

Working Group Details

Society
IEEE Instrumentation and Measurement Society
Standard Committee
IM/TET - TC41 - Traffic Enforcement Technologies
Working Group
OFDSD - On-Site Oral Fluid Drug Screening Devices Working Group
Learn More About OFDSD - On-Site Oral Fluid Drug Screening Devices Working Group
IEEE Program Manager
Patrycja Jarosz
Contact Patrycja Jarosz
Working Group Chair
John Jendzurski

Other Activities From This Working Group

Current projects that have been authorized by the IEEE SA Standards Board to develop a standard.


No Active Projects

Standards approved by the IEEE SA Standards Board that are within the 10-year lifecycle.


No Active Standards

These standards have been replaced with a revised version of the standard, or by a compilation of the original active standard and all its existing amendments, corrigenda, and errata.


No Superseded Standards

These standards have been removed from active status through a ballot where the standard is made inactive as a consensus decision of a balloting group.


No Inactive-Withdrawn Standards

These standards are removed from active status through an administrative process for standards that have not undergone a revision process within 10 years.


No Inactive-Reserved Standards
Subscribe to our Newsletter

Sign up for our monthly newsletter to learn about new developments, including resources, insights and more.